Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses

By sjmartinez • March 21, 2024

Yuen MF, Fung S, Ma X, Nguyen TT, Hassanein T, Hann HW, Elkhashab M, Nahass RG, Park JS, Jacobson IM, Ayoub WS, Han SH, Gane EJ, Zomorodi K, Yan R, Ma J, Knox SJ, Stamm LM, Bonacini M, Weilert F, Ramji A, Bennett M, Ravendhran N, Chan S, Dieterich DT, Kwo PY, Schiff ER, Bae HS, Lalezari J, Agarwal K, Sulkowski MS. Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses. JHEP Rep. 2024 Jan 18;6(4):100999. doi: 10.1016/j.jhepr.2023.100999. PMID: 38510983; PMCID: PMC10951643.

Tags: Antiviral, Cedars Sinai DoM, Core inhibitor, Digestive Diseases, Hepatitis, hepatitis B virus, Nucleos(t)ide reverse transcriptase inhibitor, Off-treatment, Open-label, Publications, Viral relapse

Association of neighborhood-level socioeconomic disadvantage and Life’s Essential 8 in early pregnancy

Venkatesh KK, Grobman WA, Huang X, Yee LM, Catov J, Simhan H, Haas DM, Mercer B, Reddy U, Silver RM, Levine LD, Chung J, Saade[...]

Generalizable, sequence-invariant deep learning image reconstruction for subspace-constrained quantitative MRI

Hu Z, Chen Z, Cao T, Lee HL, Xie Y, Li D, Christodoulou AG. Generalizable, sequence-invariant deep learning image reconstruction for subspace-constrained quantitative MRI. Magn[...]

Alterations in genes associated with cytosolic RNA sensing in whole blood are associated with coronary microvascular disease in SLE

Huo L, Naveen Kumar A, Tumurkhuu G, Bose M, Berman DS, Wallace DJ, Wei J, Ishimori M, Bairey Merz CN, Jefferies C. Alterations in genes[...]